![Chau Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Chau Cheng worked as Senior Director-Investor Relations at Immunomedics, Inc. from 2004 to 2020.
From 2020 to 2022, served as VP-Investor Relations & Corporate Communications at CytomX Therapeutics, Inc. Also held the position of Vice President-Investor Relations at CG Oncology, Inc. and.
Immunovant, Inc. Education includes an MBA from The Leonard N Stern School of Business, an undergraduate degree from the University of Bradford, and a doctorate from The Open University.
Former positions of Chau Cheng
| Companies | Position | End |
|---|---|---|
| IMMUNOVANT, INC. | Investor Relations Contact | 01/08/2024 |
| CYTOMX THERAPEUTICS, INC. | Investor Relations Contact | 01/09/2022 |
| IMMUNOMEDICS, INC. | Investor Relations Contact | 01/12/2020 |
| CG ONCOLOGY, INC. | Investor Relations Contact | - |
Training of Chau Cheng
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Bradford
 University of Bradford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Chau Cheng
